1. Home
  2. DVA vs LSCC Comparison

DVA vs LSCC Comparison

Compare DVA & LSCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DaVita Inc.

DVA

DaVita Inc.

HOLD

Current Price

$110.37

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo Lattice Semiconductor Corporation

LSCC

Lattice Semiconductor Corporation

HOLD

Current Price

$84.80

Market Cap

9.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
DVA
LSCC
Founded
1994
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Misc Health and Biotechnology Services
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
9.6B
IPO Year
1995
1989

Fundamental Metrics

Financial Performance
Metric
DVA
LSCC
Price
$110.37
$84.80
Analyst Decision
Hold
Strong Buy
Analyst Count
4
11
Target Price
$145.00
$76.18
AVG Volume (30 Days)
753.4K
1.5M
Earning Date
02-12-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
5.63
N/A
EPS
9.76
0.20
Revenue
$13,317,965,000.00
$494,889,000.00
Revenue This Year
$6.50
$4.23
Revenue Next Year
$2.97
$21.23
P/E Ratio
$11.53
$414.50
Revenue Growth
5.14
N/A
52 Week Low
$110.33
$34.69
52 Week High
$179.60
$86.69

Technical Indicators

Market Signals
Indicator
DVA
LSCC
Relative Strength Index (RSI) 33.97 66.68
Support Level $110.33 $81.01
Resistance Level $115.82 $86.69
Average True Range (ATR) 2.42 2.27
MACD -0.23 0.72
Stochastic Oscillator 19.53 88.08

Price Performance

Historical Comparison
DVA
LSCC

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

Share on Social Networks: